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Abstract: Background: Studying the adherence of the population to the Atlantic Diet (AD) could
be simplified by an easy and quickly applied dietary index. The aim of this study is to analyse the
relationship of an index measuring compliance with recommendations regarding the Atlantic diet
and physical activity with cardiovascular disease risk factors, cardiovascular risk factors, obesity
indexes and arterial stiffness markers. Methods: We included 791 individuals from the EVIDENT
study (lifestyles and arterial ageing), (52.3 ± 12 years, 61.7% women) without cardiovascular
disease. Compliance with recommendations on AD was collected through the responses to a food
frequency questionnaire, while physical activity was measured by accelerometer. The number of
recommendations being met was estimated using a global scale between 0 and 14 points (a higher
score representing greater adherence). Blood pressure, plasma lipid and glucose values and obesity
rates were measured. Cardiovascular risk was estimated with the Framingham equation. Results:
In the overall sample, 184 individuals (23.3%) scored between 0–3 on the 14-point index we created,
308 (38.9%) between 4 and 5 points, and 299 (37.8%) 6 or more points. The results of multivariate
analysis yield a common tendency in which the group with an adherence score of at least 6 points
shows lower figures for total cholesterol (p = 0.007) and triglycerides (p = 0.002). Similarly, overall
cardiovascular risk in this group is the lowest (p < 0.001), as is pulse wave velocity (p = 0.050) and the
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mean values of the obesity indexes studied (p < 0.05 in all cases). Conclusion: The rate of compliance
with the Atlantic diet and physical activity shows that greater adherence to these recommendations
is linked to lower cardiovascular risk, lower total cholesterol and triglycerides, lower rates of obesity
and lower pulse wave velocity values.
Keywords: healthy diet; diet; Mediterranean; vascular stiffness; obesity abdominal; risk factors
1. Introduction
In recent decades, the study of the effects of nutrition on health has undergone a change in
approach, with the focus moving from isolated nutrients to dietary patterns [1]. This change is partly
due to the difficulty of studying the effects of individual nutrients since these are consumed as part
of a dietary pattern alongside other nutrients, among which complex interactions take place [2–4].
The analysis of a single nutrient in this context may thus be affected by a confounding phenomenon [5]
and generate erroneous associations [6]. Some studies complement the analysis of the effect of these
dietary patterns on health by analysing the principal component and/or using a cluster analysis.
These analyses have been able, for example, to determine that within the concept of a healthy eating
pattern, the consumption of a diet rich in cereals, fish, fruit and vegetables is associated with a healthier
metabolic profile [7]. They have also allow determining that skipping breakfast or the afternoon snack
are risk factors for poor cardiovascular health [8].
Among dietary patterns, the most studied has been the Mediterranean diet and the dietary
approaches to stop hypertension (DASH). The Mediterranean diet has shown a reduction in both the
incidence and prevalence of chronic diseases like cardiovascular disease, cancer, metabolic syndrome,
diabetes, neurodegenerative diseases, as well as a reduction in overall mortality [4]. This diet is
considered one of the best dietary patterns in the framework of healthy lifestyle, probably due to
the combination of many elements with antioxidant and anti-inflammatory properties [3], thereby
constituting a useful tool for the prevention of cardiovascular disease [2,5,6] and making it one of
the best analysed in relation to cardiovascular risk and other health outcomes [9]. The DASH dietary
pattern, was originally developed to treat hypertension without medication and was associated with
substantially lower risk of coronary artery disease and stroke mortality and other cardiometabolic
advantages [10–12].
However, more recently, a pattern known as the Atlantic Diet (AD), representative of the
traditional diet of Portugal and Galicia (Northwest Spain) has been focusing the attention. Although it
has many elements in common with the Mediterranean diet (consumption of fruits and vegetables,
nuts and olive oil) and with the DASH dietary pattern (fruits, vegetables nuts, legumes or moderate
consumption of low fat dairy), the AD has some differentiating characteristics such as the increased
intake of fish and seafood, potatoes, broths with meat and cabbage, and moderate consumption of lean
meats [13]. To date, while available evidence regarding this dietary pattern is not particularly extensive,
published scientific studies have shown that it can provide important health benefits. In a case-control
study conducted in 2010 in Porto by Oliveira et al. [14], an inverse association between adherence
to AD and a lower probability of non-fatal myocardial infarction was reported. Guallar-Castillon et
al. [15], examined the association between Southern European AD (SEAD) and various biomarkers of
coronary risk, blood pressure and anthropometry. Greater adherence to the SEAD was associated with
lower levels of C-reactive protein in plasma, plasma triglycerides, insulin resistance index, albumin in
urine, urine albumin-creatinine ratio, and systolic blood pressure.
Studying the adherence of the population to this dietary pattern and its relationship with
cardiovascular disease, as well as possible comparisons with other dietary patterns, could be simplified
by an easy and quickly applied dietary index. The aim of this study is to develop a dietary index, based
on a food frequency questionnaire, which would allow a quick and easy assessment of compliance
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with the recommendations regarding the Atlantic diet and physical activity and an analysis of its
association with cardiovascular disease risk score as primary outcome and cardiovascular risk factors,
obesity indexes and arterial stiffness markers as secondary outcomes.
2. Materials and Methods
2.1. Study Design
The results of this study are a subanalysis of the EVIDENT 2 study (Lifestyles and arterial aging).
This article presents the data from the baseline assessment alone. The EVIDENT 2 study protocol [16],
with a description of data gathering methods, has been published previously. The EVIDENT 2 was a
multi-centre clinical trial aiming to assess the effect of a smartphone application with brief counselling
on improving the lifestyles in the general population.
2.2. Study Population
The EVIDENT 2 study participants were selected through random sampling from offices of
general practitioners in six health centers from Spain. For this analysis, among the 833 participants
in the EVIDENT 2 study, we included a total of 791 individuals. The remaining 42 participants did
not have valid dietary records at the baseline assessment visit and collected using a food frequency
questionnaire (FFQ). Other measures included in this study (cardiovascular risk factors and obesity
indexes) were present on the 791 participants included. Exclusion criteria were as follows: being over
70 years of age, having cardiovascular disease, heart failure, moderate or severe chronic obstructive
pulmonary disease, musculoskeletal disease which prevented walking, advanced liver, lung or kidney
disease, severe mental illness, oncological disease treated and diagnosed in the 5 years prior to the
beginning of the study, terminal illness, and pregnancy.
2.3. Ethics Approval and Consent to Participate
The study was approved by the clinical research ethics committee (CEIC) of the health care
area of Salamanca (“CEIC of Area de Salud de Salamanca”, 21 June 2013) as a coordinating centre.
It was also approved by the ethics committees of the five collaborating centres (“CEIC of Aragón
(CEICA), CEIC of IDIAP Jordi Gol, CEIC of Euskadi (CEIC-E), CEIC of Castilla la Mancha and CEIC of
the Area de Salud de Valladolid Oeste”). Subjects signed informed consent forms prior to inclusion
in the study, in accordance with the Declaration of Helsinki. Trial registration: ClinicalTrials.gov
Identifier: NCT02016014
2.4. Variables and Measuring Instruments
Assessment of compliance with recommendations on the Atlantic diet and physical activity:
Dietary intake was collected by means of a semiquantitative, self-administered food frequency
questionnaire (FFQ), using the previous year as the reference period. This questionnaire has been
validated for energy, nutrient intake and food groups, against three-day dietary records in Spain [17]
and includes 137 foods frequently used among the reference population. After receiving instructions
from the study staff, participants indicated the frequency with which each food item was consumed
over the last year using a Likert scale of nine options (never or almost never, 1–3 times a month, once a
week, 2–4 times a week, 5–6 times a week, once a day, 2–3 times a day, 4–6 times a day or more than
6 times a day). Based on the results, we estimated the daily energy consumption (kcal), as well as
the daily intake of macro and micronutrients (g). With the data of the FFQ, we have calculated an
index of adherence to the Atlantic Diet, adapting the recommendations provided by Oliveira et al. [14],
Calvo-Malvar et al. [18] and Vaz Velho et al. [13]. Oliveira et al. [14] developed an index based on a food
frequency questionnaire. This index consists of nine food groups (fresh fish, dried salt cod, red meat
and pork products, dairy products, legumes and vegetables, vegetable soup, potatoes, whole-grain
bread, and wine). Subsequently, Calvo-Malvar et al. [18] established a series of recommendations for
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good compliance with this dietary pattern which, in addition to previous ones, included olive oil,
fruit, eggs, nuts and other additional items to reduce the consumption of foods rich in animal fats,
sweets or sugar-sweetened beverages. Finally, Vaz Velho [13], and Tojo et al. [19] included in the AD
pyramid performing daily physical activity moderate to high intensity. All these recommendations
were put together for the calculation of a 14-item index (Table 1). Compliance with each of the criteria
defined in Table 1 scored one point, with the overall score ranging from 0 to 14 points (the higher the
score, the greater the adherence). After the calculation of the index, the sample has been divided into 3
groups, using the integer values closest to the tertiles according to the number of AD recommendations
met (0–3 points, 4–5 points and ≥6 points).
Table 1. Composition of the ATLANTIC diet and lifestyle index.
Components Frequency Servings Equivalents
Bread, cereals, wholegrain cereals, rice, pasta
and potatoes ≥6 servings/day
1 serving: 75 g bread, 30 g cereals, 60 g rice, 60 g
pasta, 150 g potatoes
Olive oil ≥3 servings/day 1 serving: 1 spoon
Fresh fruit ≥3 servings/day 1 serving: 1 piece or serving
Vegetables ≥2 servings/day 1 serving: 200 g
Dairy products ≥3 servings/day 1 serving: 200 g milk, 155 g yogurt, 50 g cheese
Fish and seafood ≥3 servings/week 1 serving: 130 g fish, 200 g seafood
Lean meat ≥3 servings/week 1 serving: 130 g
Eggs ≥3 servings/week 1 serving: quantity 1
Pulses ≥2 servings/week 1 serving: 150 g
Nuts, preferably chestnuts, walnuts, almonds
and hazelnuts ≥4 servings/week 1 serving: 30 g
Fatty meat, cured sausage, margarine, butter ≤4 servings/month 1 serving: 50 g fatty meat or sausage, 12 gmargarine or butter
Sweets, pastries, cakes, candies, ice cream ≤4 servings/month 1 serving: 50 g sweets, pastries or cakes, icecream quantity 1
Sugar-sweetened beverages ≤4 servings/month 1 serving: 200 cc
Moderate and or vigorous physical activity ≥60 min/day
Each issue scored with one point if it is met
Assessment of habitual physical activity: Physical activity was measured using GT3X
accelerometers, previously validated [20]. Data collected includes time spent daily (min/day) on
moderate-vigorous activities. The device was worn for seven consecutive days.
Assessment of cardiovascular risk factors: For blood pressure, three readings were taken on
each arm, using the mean of the last two from the arm with the highest values. Measurements
were obtained with an oscillometric device, OMRON M10-IT (Omron Health Care, Kyoto, Japan),
following the recommendations of the European Hypertension Society [21]. For the analysis of the
laboratory variables, a blood sample was taken after a 12-h fast. The following values of plasma glucose,
hemoglobin A1c (HbA1c) and lipid profile were measured: total plasma cholesterol, high density
lipoprotein cholesterol (HDL-C) and triglycerides. Low density lipoprotein cholesterol (LDL-C) was
estimated using the Friedewald equation except in subjects who had triglyceride levels ≥300 mg/dL
(n = 10), in which case we used 299 mg/dL for the calculation of triglycerides. Hypertension was
recorded with systolic blood pressure values of ≥140 mmHg and/or diastolic blood pressure values of
≥90 mmHg or if the subject was on antihypertensive medication [22]. Type 2 diabetes mellitus was
present with HbA1c≥ 6.5%, fasting plasma glucose≥ 126 mg/dL, 2 h of plasma glucose≥ 200 mg/dL
during an oral glucose tolerance test, or random plasma glucose ≥ 200 mg/dl for a patient with classic
symptoms of hyperglycemia or hyperglycaemic crisis or under antidiabetic treatment [23]. Information
regarding drugs used for hypertension, type 2 diabetes and dyslipidemia was gathered by accessing
data from the electronic medical records and then confirmed by the subjects themselves. Smoking
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history was assessed through questions about the participant’s smoking status (smoker/non-smoker).
We considered smokers to be subjects who currently smoke or who stopped smoking less than one
year ago.
Cardiovascular risk assessment (CVR): This was estimated using the published risk equation
based on the Framingham study [24] to assess general cardiovascular disease risk and 10-year risk
of individual cardiovascular events (coronary, cerebrovascular, and peripheral arterial disease and
heart failure). Risk factors used include age, total cholesterol, high-density lipoprotein cholesterol and
SBP as quantitative variables, and gender, drug treatment for hypertension, smoking and history of
diabetes mellitus as dichotomous variables. The 791 participants who meet the selection criteria allow
detecting a minimum difference in cardiovascular risk of three percentage points between two of the
three groups into which we have classified AD adherence, assuming an alpha risk of 0.05 and a beta
risk of 0.2 in bilateral contrast. This minimum difference was based on the results found after a diet
and aerobic exercise program intervention, which achieved a reduction of 3.0 points on cardiovascular
risk [25].
Anthropometric variables: Body weight was measured twice with an approved electronic
scale (Seca 770, Medical Scale and Measurement Systems, Birmingham, UK) after calibration
(accuracy ± 0.1 kg), with readings rounded to 100 g. Height was measured with a stadiometer
(Seca 222, Medical Scale and Measurement Systems, Birmingham, UK), recording the average of two
measurements. Body mass index (BMI) was calculated using the formula weight (kg) divided by height
squared (m2). Waist and hip circumference were measured using a flexible tape measure following the
recommendations of the Spanish Society for the Study of Obesity in 2007 [26]. All measurements were
taken with the patient standing, barefoot and in light clothing. With these values, the waist-height index
and the waist-hip index were subsequently calculated by means of the ratio of waist circumference to
height or hip circumference, respectively. The adiposity index was based on the equation (Adiposity
index = ((hip circumference)/((height) × (1.5)) − 18)) [27].
Analysis of pulse wave velocity (PWV): Pulse wave velocity was recorded in the Salamanca
cohort (n = 291). This cohort had similar age and gender distribution to that the entire sample.
The measurement was made with the patient in supine position using the SphymgoCor System (AtCor
Medical Pty Ltd. Head Office, West Ryde, Australia), following the recommendations of the Van Bortel
et al. consensus [28]. The pulse waves of the carotid and femoral arteries were analysed, and the delay
was estimated with respect to the ECG wave. A tape measure was used to determine the distance from
the sternal fork to the carotid and femoral artery sensor locations. Velocity was estimated in m/second.
2.5. Statistical Analysis
Results are expressed as means ± standard deviation for quantitative variables and by frequency
distribution in the case of qualitative variables. The differences of means for continuous variables
across the three groups were assessed through one-way analysis of variance (ANOVA) for independent
samples, using the DMS method in post-hoc contrasts. An analysis of the covariance (ANCOVA) was
also carried out, including as an independent variable the Atlantic diet and lifestyle index divided
into the three categories described above, and as dependent variables cardiovascular risk, blood
pressure, cholesterol, triglycerides, glucose, pulse wave velocity and anthropometric markers such
as BMI, adiposity index, waist/height and waist/hip ratio. This analysis was adjusted only for the
energy intake in the case of the cardiovascular risk to avoid collinearity. For the rest of the dependent
variables, the analysis was controlled for age, gender and calorie intake (kcal) in all models, for the
use of antihypertensive drugs in the case of blood pressure, for lipid-lowering drugs in the case of
cholesterol and triglycerides, for antidiabetics in the case of glucose, and for antihypertensive drug
treatment, blood pressure and smoking status in the pulse wave velocity analysis. Statistical analysis
was performed with IBM SPSS Statistics for Windows, Version 23.0. (Armonk, NY, USA: IBM Corp.).
A p value of <0.05 was considered statistically significant.
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3. Results
Of the 791 individuals selected (52.3± 12 years, 61.7% women), 33.1% were hypertensive and 7.3%
had type 2 diabetes mellitus (Table 2). The scores on the 14-point index scale of the total sample were
as follows: 184 participants (23.3%) registered 0–3, 308 (38.9%) between 4 and 5 points, and 299 (37.8%)
6 or more points. The average index score assessing AD adherence was 4.9 points ± 1.7. Among the
14 items proposed, the one with the highest level of adherence (90.5%) was the consumption of at least
three servings per week of fish or seafood. Conversely, the consumption of at least six servings/day of
bread, cereals, wholegrain cereals, rice, pasta and potatoes was the item with the lowest compliance
percentage (2.8%) (Table 3).
Table 2. Baseline characteristics and clinical characteristics of the study population.
Measures Overall (n = 791). Mean or n (SD or %)
Age (years) 52.3 (12.0)
Gender, Female (n, %) 488 (61.7)
Hypertension (n, %) 262 (33.1)
Diabetes (n, %) 58 (7.3)
Antihypertensive agents (n, %) 193 (24.4)
Hypoglycemic agents (n, %) 50 (6.3)
Lipid-lowering agents (n, %) 155 (19.6)
SBP (mmHg) 123.9 (16.1)
DBP (mmHg) 76.2 (9.8)
Heart rate (bpm) 70.9 (11.5)
Glycated hemoglobin (%) 5.5 (0.6)
Serum glucose (mg/dL) 90.2 (17.5)
Total cholesterol (mg/dL) 204.0 (36.0)
HDL-cholesterol (mg/dL) 58.7 (15.1)
LDL-cholesterol (mg/dL) 124.5 (31.6)
Tryglicerides (mg/dL) 110.4 (65.8)
Fibrinogen (mg/dL) 358.9 (85.1)
BMI (kg/m2) 27.8 (4.9)
Waist circumference (cm) 95.1 (13.1)
Hip circumference (cm) 105.0 (9.4)
Waist-height ratio 0.58 (0.78)
Waist-hip ratio 0.91 (0.10)
Adiposity index 27.6 (6.4)
CVR 10.1 (10.4)
Moderate and or vigorous physical activity (min/day) 65.0 (30.9)
Categorical variables are expressed as n (%) and continuous variables as mean ± standard deviation (SD). SBP:
Systolic blood pressure; DBP: Diastolic blood pressure; HDL: High-density lipoprotein cholesterol; LDL: Low-density
lipoprotein cholesterol; BMI: Body mass index; CVR: Cardiovascular risk; cfPWV: Carotid femoral pulse
wave velocity.
Nutrients 2019, 11, 742 7 of 13
Table 3. Adherence to the ATLANTIC diet and lifestyle index.
Atlantic Diet Adherence Items n (%)
Bread, cereals, wholegrain cereals, rice, pasta and potatoes (≥6 servings/day) 22 (2.8)
Olive oil (≥3 servings/day) 195 (24.7)
Fresh fruit (≥3 servings/day) 253 (32.0)
Vegetables (≥2 servings/day) 362 (45.8)
Dairy products (≥3 servings/day) 265 (33.5)
Fish and seafood (≥3 servings/week) 716 (90.5)
Lean meat (≥3 servings/week) 513 (64.9)
Eggs (≥3 servings/week) 47 (5.9)
Pulses (≥2 servings/week) 71 (9.0)
Nuts, preferably chestnuts, walnuts, almonds and hazelnuts (≥4 servings/week) 195 (24.7)
Fatty meat, cured sausage, margarine, butter (≤4 servings/month) 71 (9.0)
Sweets, pastries, cakes, candies, ice cream (≤4 servings/month) 144 (18.2)
Sugar-sweetened beverages (≤4 servings/month) 596 (75.3)
Moderate and or vigorous physical activity (≥60 min/day) 409 (51.7)
There are differences between the three groups with respect to energy consumption (kcal). The diet
of the group with the highest adherence (6 points or more) has more calories, together with a lower
percentage of saturated fat and a higher percentage of proteins, with the total amount of fat being
similar to that consumed in the other groups (Table 4).
Table 4. Energy intake and daily nutrients intake by score of ATLANTIC diet and lifestyle index.
Overall
(n = 791)
Mean or n
(SD or %)
0–3 Points
(n = 184)
Mean or n
(SD or %)
4–5 Points
(n = 308)
Mean or n
(SD or %)
≥6 Points
(n = 299)
Mean or n
(SD or %)
p Value
Energy intake (kcal/day) *#& 2477 (786) 2103 (600) 2447 (759) 2738 (816) <0.001
Carbohydrate (%) * 42.3 (7.0) 43.4 (6.8) 41.8 (6.9) 42.3 (7.1) 0.046
Protein (%) *#& 17.7 (3.3) 16.7 (2.9) 17.5 (3.4) 18.4 (3.3) <0.001
Total fat (%) 37.5 (6.4) 37.0 (6.1) 38.0 (6.3) 37.3 (6.7) 0.219
Saturated fat (%) *# 10.9 (2.5) 11.5 (2.5) 11.0 (2.5) 10.4 (2.4) <0.001
Fiber (g/day) *#& 27 (11) 20 (6) 26 (9) 34 (11) <0.001
Cholesterol (g/day) *#& 460 (177) 388 (151) 462 (173) 503 (182) <0.001
Categorical variables are expressed as n (%) and continuous variables as mean ± standard deviation. p: statistically
significant differences (p < 0.05); Post-hoc contrasts (DMS): * Between 0–3 and 4–5 points, # Between 0–3 and
≥6 points, & Between 4–5 and ≥6 points.
In terms of groups, the one comprising individuals with an AD adherence score of at least
6 points was characterized by being older (55.1 years) and having a higher percentage of women
(68.9%) among them. In an unadjusted model, no differences were found between the groups with
different AD adherence in either the variables related to cardiovascular risk factors or in the use of
drugs. No differences were found in the figures for blood pressure or metabolic control, nor in the
global values of cardiovascular risk or carotid-femoral pulse wave velocity. However, the group with
the highest adherence showed lower levels of plasma triglycerides, as well as lower BMI and waist
circumference values (Table 5).
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Table 5. Cardiovascular risk, mean cardiovascular risk factors and obesity indexes by score of ATLANTIC diet and lifestyle index. a
Unadjusted Means Adjusted Means b
0–3 Points
(n = 184)
Mean or n
(SD or %)
4–5 Points
(n = 308)
Mean or n
(SD or %)
≥6 Points
(n = 299)
Mean or n
(SD or %)
p Trend 0–3 Points
(n = 184)
Mean or n
(SD or %)
4–5 Points
(n = 308)
Mean or n
(SD or %)
≥6 Points
(n = 299)
Mean or n
(SD or %)
p trend
CVR 10.2 (11.1) 9.4 (9.0) 10.6 (11.2) 0.377 12.6 (9.0) 9.7 (8.6) 8.8 (8.9) <0.001 *#
C SBP (mmHg) 123.5 (18.2) 124.3 (14.8) 123.6 (16.2) 0.829 124.3 (14.4) 124.5 (13.7) 122.9 (14.3) 0.344
Serum glucose (mg/dL) 90.4 (18.6) 90.0 (17.8) 90.3 (16.5) 0.970 90.9 (14.7) 90.8 (14.0) 89.2 (14.6) 0.326
Total cholesterol (mg/dL) 199.0 (32.9) 208.4 (37.1) 202.5 (36.0) 0.013 *& 203.1 (36.8) 208.7 (34.6) 199.7 (36.2) 0.007 &
Tryglicerides (mg/dL) 122.7 (70.5) 112.9 (77.4) 100.3 (45.0) <0.001 #& 122.6 (67.8) 113.3 (63.9) 99.9 (67.0) 0.002 #&
Fibrinogen (mg/dL) 355.9 (90.2) 356.4 (87.1) 363.3 (79.7) 0.572 363.3 (94.5) 356.7 (88.4) 358.3 (93.6) 0.744
cfPWV (m/s) n = 291 7.1 (1.6) 7.1 (1.3) 7.4 (1.3) 0.166 7.4 (5.5) 7.2 (5.2) 7.2 (5.5) 0.050 *#
BMI (kg/m2) 28.3 (5.6) 28.2 (5.0) 27.2 (4.2) 0.016 #& 28.6 (5.0) 28.2 (4.7) 27.0 (5.0) 0.001 #&
Waist-height ratio 0.58 (0.08) 0.59 (0.08) 0.58 (0.07) 0.184 0.59 (0.08) 0.59 (0.07) 0.57 (0.08) 0.001 #&
Waist-hip ratio 0.91 (0.10) 0.91 (0.11) 0.90 (0.08) 0.211 0.91 (0.08) 0.91 (0.09) 0.90 (0.09) 0.121
Adiposity index 27.1 (6.7) 28.0 (6.8) 27.3 (5.8) 0.252 28.2 (6.3) 28.1 (6.0) 26.6 (6.3) 0.004 #&
a Results are reported as mean ± standard deviation. p: statistically significant differences (p < 0.05). Post-hoc contrasts (DMS): * Between 0–3 and 4–5 points, # Between 0–3 and ≥6 points,
& Between 4–5 and ≥6 points, b Adjusted means for age, gender and total energy intake by analysis of covariance (ANCOVA). Model for SBP adjusted, also for antihypertensive drugs.
Model for serum glucose adjusted, also, for antidiabetic drugs. Model for tryglicerides and total cholesterol adjusted, also, for lipid-lowering drugs. Model for the pulse wave velocity
analysis adjusted, also, for antihypertensive drug treatment, blood pressure and smoking status. Model for CVR adjusted only for energy intake. c SBP: Systolic blood pressure; CVR:
Cardiovascular risk; cfPWV: Carotid femoral pulse wave velocity; BMI: Body mass index.
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In the adjusted model, controlling for potential confounding variables, the multivariate analysis
yields a common tendency in which the group of those adhering to at least 6 points in the adherence
index show lower total cholesterol figures (p = 0.007), and triglycerides (p = 0.002). Systolic blood
pressure and glucose follow the same trend, without reaching statistical significance. Similarly, their
overall cardiovascular risk is the lowest (p < 0.001), as is their pulse wave velocity figure (p = 0.050)
(Table 5). Also, higher compliance with AD items is associated with lower figures of body mass index,
waist circumference and waist-height index.
4. Discussion
Developed from a food frequency questionnaire, the index created to assess the Atlantic Diet
(AD) and lifestyle allows adherence to the recommendations described for this dietary pattern
to be quantified. The main results show that greater compliance with these recommendations is
associated with lower cardiovascular risk and lower figures for some cardiovascular risk factors such
as cholesterol and triglycerides. Likewise, a higher score in this index is linked to lower figures in
all the anthropometric markers studied. Finally, this study explores for the first time the relationship
between this dietary pattern and arterial stiffness, showing an inverse relationship between them.
The higher the level of adherence, the lower the pulse wave velocity.
The study of the health effects of certain dietary patterns requires valid instruments which are
easy to administer in clinical practice. The PREDIMED study group (Effects of the Mediterranean
diet in the primary prevention of cardiovascular disease) developed a questionnaire of 14 items [29]
to assess the adherence to the Mediterranean Diet which has been used in innumerable subsequent
studies. This questionnaire correlated very strongly with a food frequency questionnaire [29]. However,
although AD has also been observed to have significant positive effects on health, there is no widely
used questionnaire to assess compliance with its recommendations. The index created by our group,
presented in this manuscript, includes all these recommendations, adapting the responses to a food
frequency questionnaire widely used in other research [30,31]. The composition and validation
of an AD adherence questionnaire using this index may be of interest in initiating a debate in
which both dietary patterns (Mediterranean and Atlantic) can be compared in terms of predicting
cardiovascular disease.
To date, not a great deal of evidence has been generated regarding the relationship of the AD
dietary pattern with health. The work of Guallar-Castillon et al. [15] has yielded the most outstanding
results. This study used the nine-component index, which we described in the previous paragraph,
finding an average compliance of 2.9 points out of 9 possible pints among the 10,231 individuals
studied. This represents relatively low adherence to AD and coincides with that found in the EVIDENT
study (4.9 points ± 1.7) out of 14 possible points. Both studies concur in that greater compliance
with the recommendations of this dietary pattern is related to lower values for blood pressure or
plasma levels of cholesterol and triglycerides. However, the EVIDENT study is the first to explore
the possible association with global cardiovascular risk, calculated by a risk equation. Among the
possible explanations for the results found in this study, we can point out that individually, many
of the components of AD have been associated with cardiovascular disease, including the clearest
distinguishing aspect with respect to the Mediterranean diet or the DASH diet, which is a high
consumption of fish [32]. The creation of this index allows measuring the combined effect of all these
components, as well as their possible interactions, on cardiovascular risk or cardiovascular risk factors.
Oliveira et al. [14] concluded that adherence to AD was associated with a lower probability of non-fatal
myocardial infarction. These results could potentially be explained by the possible relationship
indicated in this study, considering carotid-femoral pulse wave velocity, a marker of arterial stiffness,
as a surrogate marker in the development of cardiovascular disease [33]. These results may therefore
be the beginning of a line of research on the effects of AD in subclinical atherosclerosis assessed
through arterial stiffness. Furthermore, the association of the AD index with the anthropometric
markers exploring both general obesity (BMI, adiposity index) and abdominal obesity (waist-hip
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index and waist-height index) is also of relevance. This relationship may be mediated by the increase
in some inflammatory markers such as insulin resistance or C-reactive protein [15]. The GALIAT
clinical trial [18] will clarify these issues as it is the first clinical trial to analyse the effects of AD on
adiposity markers.
The present study presents a series of limitations. The design of the study (being cross-sectional)
does not allow causal relationships to be established between compliance with the recommendations
of the AD and the variables studied, but it may be useful when proposing intervention or longitudinal
studies to clarify the role of this dietary profile on health like those developed for the DASH diet
or the Mediterranean diet. The AD index was created using the responses of the participants to a
food frequency questionnaire which was previously validated in the reference population (Spanish
population). Some studies indicate that FFQ may overestimate food consumption compared to
other assessment instruments [34–36]. The population used for the analysis presented comprised
participants of a clinical trial (EVIDENT 2), the aim of which was to measure the effectiveness of using
a smartphone application in the improvement of lifestyles. However, the data used from the food
frequency questionnaire are those corresponding to the first baseline assessment visit, at which stage
no intervention of any kind had yet been carried out.
5. Conclusions
Based on the rate of compliance with the Atlantic diet and the lifestyle, developed from a food
frequency questionnaire, the main results show that greater compliance with these recommendations
is related to lower cardiovascular risk and lower average values for cholesterol and triglycerides, lower
rates of obesity and lower figures for pulse wave velocity.
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